By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Inspire Pharmaceuticals, Inc. 

4222 Emperor Boulevard
Suite 200
Durham  North Carolina  27703  U.S.A.
Phone: 919-941-9777 Fax: 919-941-9797


SEARCH JOBS
Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire’s goal is to build and commercialize a sustainable portfolio of innovative new products based on its technical, scientific and commercial expertise. The most advanced compounds in Inspire’s clinical pipeline are denufosol tetrasodium for cystic fibrosis and PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for dry eye, which are both in Phase 3 development, and AZASITE® (azithromycin ophthalmic solution) 1% for blepharitis, which is in Phase 2 development. Inspire receives revenues related to the promotion of AZASITE for bacterial conjunctivitis, the co-promotion of ELESTAT® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and royalties based on net sales of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% for dry eye.

For more information, visit www.inspirepharm.com.


Key Statistics


Email: info@inspirepharm.com
Ownership: Public

Web Site: Inspire Pharmaceuticals, Inc.
Employees:
Symbol: ISPH
 









Company News
Merck & Co., Inc. (MRK) to Close Inspire Pharmaceuticals, Inc. (ISPH) Facility, 51 Jobs Axed 7/1/2011 7:23:06 AM
Merck & Co., Inc. (MRK) Completes Acquisition of Inspire Pharmaceuticals, Inc. (ISPH) 5/16/2011 10:07:57 AM
Merck & Co., Inc. (MRK) Announces Successful Completion of Tender Offer for Shares of Inspire Pharmaceuticals, Inc. (ISPH) With Over 75 Percent of Shares Tendered 5/13/2011 10:13:40 AM
Inspire Pharmaceuticals, Inc. (ISPH) Reports First Quarter 2011 Financial Results 5/10/2011 10:31:18 AM
Inspire Pharmaceuticals, Inc. (ISPH) Reports First Quarter 2011 Financial Results 5/10/2011 10:19:32 AM
Merck & Co., Inc. (MRK) and Inspire Pharmaceuticals, Inc. (ISPH) Announce Expiration of Hart-Scott-Rodino Act Waiting Period Relating to Tender Offer for Shares of Inspire 4/28/2011 9:58:33 AM
Inspire Pharmaceuticals, Inc. (ISPH) Postpones Annual Meeting of Stockholders Due to Recently Announced Tender Offer 4/22/2011 7:53:18 AM
Inspire Pharmaceuticals, Inc. (ISPH) Announces Webcast of Presentation at Cowen and Company Health Care Conference 3/3/2011 9:32:30 AM
Inspire Pharmaceuticals, Inc. (ISPH) Announces Webcast of Presentation at Citi Global Healthcare Conference 2/24/2011 10:37:22 AM
Inspire Pharmaceuticals, Inc. (ISPH) Reports Fourth Quarter and Full Year 2010 Financial Results 2/17/2011 9:39:55 AM
12345678910...
//-->